{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:32:05Z","timestamp":1792931525553,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1023\/a:1024122706337","type":"journal-article","created":{"date-parts":[[2003,9,12]],"date-time":"2003-09-12T17:56:22Z","timestamp":1063389382000},"page":"291-306","source":"Crossref","is-referenced-by-count":95,"title":["Antipsychotic Drugs and QT Interval Prolongation"],"prefix":"10.1007","volume":"74","author":[{"given":"Wojciech","family":"Zareba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"460945_CR1","unstructured":"National Association of Chain Drug Stores: 2000 Community Pharmacy Results, Alexandria, VA, 2001."},{"key":"460945_CR2","volume-title":"Building a safer health system","author":"o. Q. o. H. C. i. A. I. o. M. Committee","year":"2000","unstructured":"Committee on Quality of Heath Care in America: Institute of Medicine: To err is human: Building a safer health system, Washington, DC, National Academy Press, 2000."},{"key":"460945_CR3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz B, Corey PN: Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279:1200-1205, 1998.","journal-title":"JAMA"},{"key":"460945_CR4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","volume":"84","author":"AJ Moss","year":"1991","unstructured":"Moss AJ, Schwartz PJ, Crampton RS, et al: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 84:1136-1144, 1991.","journal-title":"Circulation"},{"issue":"Suppl1","key":"460945_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00002018-199921001-00002","volume":"21","author":"AJ Moss","year":"1999","unstructured":"Moss AJ: The QT interval and torsades de pointes. Drug safety 21(Suppl 1):5-10, 1999.","journal-title":"Drug safety"},{"key":"460945_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1542-474X.2001.tb00127.x","volume":"6","author":"AJ Moss","year":"2001","unstructured":"Moss AJ, Zareba W, Benhorin J, et al: ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: Task force summary. Annals of Noninvasive Electrocardiology 6:333-341, 2001.","journal-title":"Annals of Noninvasive Electrocardiology"},{"key":"460945_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1542-474X.2000.tb00076.x","volume":"5","author":"W Zareba","year":"2000","unstructured":"Zareba W: Dispersion of repolarization: Time to move beyond QT dispersion. Annals of Noninvasive Electrocardiology 5:373-381, 2000.","journal-title":"Annals of Noninvasive Electrocardiology"},{"key":"460945_CR8","first-page":"353","volume":"7","author":"HC Bazett","year":"1920","unstructured":"Bazett HC: An analysis of time relations of electrocardiograms. Heart 7:353-367, 1920.","journal-title":"Heart"},{"key":"460945_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","volume":"53","author":"LS Fridericia","year":"1920","unstructured":"Fridericia LS: Duration of systole in electrocardiogram. Acta Medica Scandinavica 53:469, 1920.","journal-title":"Acta Medica Scandinavica"},{"key":"460945_CR10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","volume":"70","author":"A Sagie","year":"1992","unstructured":"Sagie A, Larson MG, Goldberg RJ, et al: An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). The American Journal of Cardiology 70:797-801, 1992.","journal-title":"The American Journal of Cardiology"},{"key":"460945_CR11","first-page":"694","volume":"1","author":"M Hodges","year":"1983","unstructured":"Hodges M, Salerno D, Erlien D: Bazett's QT correction reviewed: Evidence that alinear QT correction for heart rate is better. Journal of the American College of Cardiology 1:694, 1983.","journal-title":"Journal of the American College of Cardiology"},{"key":"460945_CR12","first-page":"690","volume":"8","author":"PM Rautaharju","year":"1992","unstructured":"Rautaharju PM, Zhou SH, Wong S, et al: Sex differences in the evolution of electrocardiographic QT interval with age. The Canadian Journal of Cardiology 8:690-695, 1992.","journal-title":"The Canadian Journal of Cardiology"},{"key":"460945_CR13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/0735-1097(94)90654-8","volume":"23","author":"J Karjalainen","year":"1994","unstructured":"Karjalainen J, Viitasalo M, Manttari M: Relation between QT intervals and heart rates from 40-to 120 beats\/min in rest electrocardiogram of men and a simple method to adjust QT interval values. Journal of the American College of Cardiology 23:1547-1553, 1994.","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl1","key":"460945_CR14","first-page":"1140","volume":"85","author":"AJ Moss","year":"1992","unstructured":"Moss AJ, Robinson J: Clinical features of the idiopathic long QT syndrome. Circulation 85(Suppl 1):1140-1144, 1992.","journal-title":"Circulation"},{"key":"460945_CR15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","volume":"339","author":"W Zareba","year":"1998","unstructured":"Zareba W, Moss AJ, Schwartz PJ, et al: Influence of the genotype on the clinical course of the long QT syndrome. The New England Journal of Medicine 339:960-965, 1998.","journal-title":"The New England Journal of Medicine"},{"key":"460945_CR16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/0735-1097(95)60383-2","volume":"26","author":"W Zareba","year":"1995","unstructured":"Zareba W, Moss AJ, le Cessie S: Risk of cardiac events in family members of patients with long QT syndrome. Journal of the American College of Cardiology 26:1685-1691, 1995.","journal-title":"Journal of the American College of Cardiology"},{"key":"460945_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(00)00716-6","volume":"36","author":"CE Chiang","year":"2000","unstructured":"Chiang CE, Roden DM: The long QT syndromes: Genetic basis and clinical implications. Journal of the American College of Cardiology 36:1-12, 2000.","journal-title":"Journal of the American College of Cardiology"},{"key":"460945_CR18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/hc1002.105231","volume":"105","author":"F. A. Antzelevitch","year":"2002","unstructured":"Antzelevitch Fadi AG, Yan GX, Antzelevitch C, et al: Unique topographical distribution of M cells underlies reentrant mechanism of torsades de pointes in the long-QT syndrome. Circulation, 105:1247-1253, 2002.","journal-title":"Circulation"},{"key":"460945_CR19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1540-8167.2000.tb00077.x","volume":"11","author":"DM Roden","year":"2000","unstructured":"Roden DM: Acquired long QT syndromes and the risk of proarrhythmia. Journal of Cardiovascular Electrophysiology 11:938-940, 2000.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"460945_CR20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.285.10.1322","volume":"285","author":"I Rodriguez","year":"2001","unstructured":"Rodriguez I, Kilborn MJ, Liu XK, et al: Drug-induced QT prolongation in women during the menstrual cycle. JAMA 285:1322-1326, 2001.","journal-title":"JAMA"},{"key":"460945_CR21","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.180223197","volume":"97","author":"F Sesti","year":"2000","unstructured":"Sesti F, Abbott GW, Wei J, et al: A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proceedings of the National Academy of Sciences of the United States of America 97:10613-10618, 2000.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"460945_CR22","first-page":"546","volume":"89","author":"HG Kelly","year":"1963","unstructured":"Kelly HG, Fay JE, Lavery SG: Thioridazine hydrochloride (Mellaril): Its effects on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Canadian Medical Association Journal 89:546-554, 1963.","journal-title":"Canadian Medical Association Journal"},{"key":"460945_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9149(76)90316-7","volume":"37","author":"NO Fowler","year":"1976","unstructured":"Fowler NO, McCall D, Chou TC, et al: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. The American Journal of Cardiology 37:223-230, 1976.","journal-title":"The American Journal of Cardiology"},{"key":"460945_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1991.tb01421.x","volume":"84","author":"OP Mehtonen","year":"1991","unstructured":"Mehtonen OP, Aranko K, Malkonen L, et al: A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scandinavica 84:58-64, 1991.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"460945_CR25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.98.2.482","volume":"98","author":"M Kriwisky","year":"1990","unstructured":"Kriwisky M, Perry GY, Tarchitsky D, et al: Haloperidol-induced torsades de pointes. Chest 98:482-484, 1990.","journal-title":"Chest"},{"key":"460945_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0033-3182(95)71609-7","volume":"36","author":"N Hunt","year":"1995","unstructured":"Hunt N, Stern TA: The association between intravenous haloperidol and torsades de pointes: Three cases and a literature review. Psychosomatics 36:541-549, 1995.","journal-title":"Psychosomatics"},{"key":"460945_CR27","unstructured":"Sertindole NDA 20-644, Rockville, MD, Food and Drug Administration, Psychopharmacological Drugs Advisory Committee, 1996."},{"key":"460945_CR28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004714-200006000-00005","volume":"20","author":"DA Flockhart","year":"2000","unstructured":"Flockhart DA, Drici MD, Kerbusch T, et al: Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. Journal of Clinical Psychopharmacology 20:317-324, 2000.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"460945_CR29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.21.9.871.34565","volume":"21","author":"JD Hoehns","year":"2001","unstructured":"Hoehns JD, Standord RH, Geraets DR, et al: Torsades de pointes associated with chlorpromazine: Case report and review of associated ventricular arrhythmias. Pharmacotherapy 21:871-883, 2001.","journal-title":"Pharmacotherapy"},{"key":"460945_CR30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","volume":"93","author":"JP Warner","year":"1996","unstructured":"Warner JP, Barnes TR, Henry JA: Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatrica Scandinavica 93:311-313, 1996.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"460945_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00004714-200006000-00006","volume":"20","author":"I Modai","year":"2000","unstructured":"Modai I, Hirschmann S, Rava A, et al: Sudden death in patients receiving clozapine treatment: A preliminary investigation. Journal of Clinical Psychopharmacology 20:325-327, 2000.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"460945_CR32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","volume":"325","author":"S Hennessy","year":"2002","unstructured":"Hennessy S, Bilker WB, Knauss JS, et al: Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data. BMJ 325:1070-1074, 2002.","journal-title":"BMJ"},{"key":"460945_CR33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","volume":"58","author":"WA Ray","year":"2001","unstructured":"Ray WA, Meredith S, Thapa PB, et al: Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry 58:1161-1167, 2001.","journal-title":"Archives of General Psychiatry"},{"key":"460945_CR34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","volume":"450","author":"S Kongsamut","year":"2002","unstructured":"Kongsamut S, Kang J, Chen X, et al: A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. European Journal of Pharmacology 450:37-41, 2002.","journal-title":"European Journal of Pharmacology"},{"key":"460945_CR35","unstructured":"Gordon M: Memorandum from the Division of CardioRenal Drug Products Consutlation Regarding Ziprasidone. NDA # 20825, study report of Clinical Pharmacology Protocol #128-054. June 14, 2000. Retrieved from www.fda.gov\/ohrms\/dockets\/ac00\/backgrd\/3619b1b.pdf."},{"key":"460945_CR36","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","volume":"264","author":"BP Monahan","year":"1990","unstructured":"Monahan BP, Ferguson CL, Killeavy ES, et al: Torsades de pointes occurring in association with terfenadine use. JAMA 264:2788-2790, 1990.","journal-title":"JAMA"},{"key":"460945_CR37","unstructured":"International Registry for Drug-Induced Arrhythmias. Retrived November 20, 2002, from www.qtdrugs.org."},{"key":"460945_CR38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9343(99)00241-7","volume":"107","author":"AM Walker","year":"1999","unstructured":"Walker AM, Sznele P, Weatherby LB: The risk of serious arrhythmias among cisparide users in the United Kingdom and Canada. The American Journal of Medicine 107:356-362, 1999.","journal-title":"The American Journal of Medicine"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024122706337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1024122706337\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024122706337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:43:19Z","timestamp":1754397799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1024122706337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["460945"],"URL":"https:\/\/doi.org\/10.1023\/a:1024122706337","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}